Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
Nasir M. Idkaidek, Ph.D.
Advertisement
Articles by Nasir M. Idkaidek, Ph.D.
Advertisement
Latest Updated Articles
Gastric-State-Controlled Bioequivalence StudiesPublished: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
RNAnalytics’ Viktoria Enkmann Ponders Nanoparticle Characterization Advances at CPHI Frankfurt: Part One
5
